 RICHMOND, Va.--BUSINESS WIRE--Aditxt, Inc. Nasdaq: ADTX, a biotech innovation company with a mission to improve the health of the immune system, announced today that it has entered into definitive agreements with certain institutional investors to purchase 4,583,334 shares of its common stock at a purchase price of 2.40 per share in a registered direct offering priced at-the-market under Nasdaq rules, for gross proceeds of approximately 11.0 million, before payment of commissions and expe 